APC News
OFA v. Califf: The latest
If you missed our email earlier this week, here’s an update for you on the Outsourcing Facilities Association/Farmakeio lawsuit against FDA.
January 17, 2025
Reason #2 to come to the APC Owner Summit
Our second keynote will help you plan your business strategy.
January 17, 2025
ADA parrots drugmakers on GLP-1 copies
We call out the American Diabetes Association's 'alternative facts' about compounded GLP-1s
January 17, 2025
A good time to sharpen your skills
It's time to get up to snuff when it comes to compounding best practices (and we can help).
January 17, 2025
Lilly intervenes in OFA lawsuit against FDA
Lilly says the FDA isn’t allowed to decide when compounders can compound FDA-approved drugs.
January 10, 2025
Reason #1 to come to the APC Owner Summit
"Turning Science into Stories" with Andrew Buck will teach you how to turn facts into stories that will connect with both rational and emotional audiences.
January 10, 2025
Earlier news
January 10, 2025
Why you need to sign up for an APC Package Deal — and why now is the right time
The beginning of the calendar year is the best time to be grab a package deal.
December 20, 2024
FDA doubles down: Tirzepatide is off shortage
...but that doesn't mean the issue is completely settled.
December 20, 2024
A couple of state updates
Good news from Alabama, but a problem in Massachusetts
December 20, 2024
Defending GLP-1 compounding
The latest letters APC's been sending to oppose efforts to restrict compounding
December 20, 2024
Thumbs-up for FDA crackdown
APC was thrilled when the FDA announced it was taking action against illegal online businesses claiming to sell “research-grade” compounds.
December 20, 2024
A PANS/PANDAS explainer
For your patients: Information about a couple of underdiagnosed pediatric mental health conditions
December 20, 2024
What, a year?
In the final board chair column of the year, here are our top 7 accomplishments in 2024.
December 13, 2024
“Simply not a rational approach to regulating an industry”
This week APC offered its final (and pointed) suggestions to the California Board of Pharmacy on their proposed significant – and we would say unjustified – changes to their compounding regulations.
December 13, 2024
Get a cease and desist letter from Verrica?
APC has heard reports from several pharmacies that have received them — here's what to know.
December 12, 2024
PCF awards state association CE grants
The Pharmacy Compounding Foundation has awarded $1,500 grants to eight state pharmacy associations.
December 6, 2024
Compounding vs. counterfeit — ABC News gets it
When ABC News wanted to do a story on compounded GLP-1s, it turned to APC. Of course.
December 6, 2024
No no, Novo!
Novo Nordisk asked the FDA to put semaglutide on the Demonstrably Difficult to Compound (DDC) list, and now APC has formally responded, pulling exactly zero punches.
